Delivery Order SPE2DB20D3505-SPE2DB25FV0U4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $47,260.15 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $1,782.75, represents a non-competitive, non-set-aside award with an ultimate completion date of July 25, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,831.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. to supply 60-count Naltrexone 50 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $138,740 to Amerisourcebergen Drug Corporation to provide 50mg naltrexone tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required between September 7-8, 2023. The order was placed under an existing DLA contract vehicle to support the agency's supply chain needs. No set-aside designation or subcontractors were identified. The...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp in the amount of $4,768.43. The order is for 4565427144 - Naltrexone 50 MG Tablet 60s, which are pharmaceutical products used to treat opioid dependence. The delivery order falls under the DLA's Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999, that provides a range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency Troop Support Medical awarded a $1,434 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50mg naltrexone tablets. Under this single award, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 3rd to fulfill the agency's requirement. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite...
- This contract award is for the supply of Naltrexone 50 mg tablets to the Defense Logistics Agency (DLA). The $1,562.28 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 22, 2024, with a completion date of June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,788.48 from the Defense Logistics Agency (DLA) to supply 30 tablets of the 50mg Naltrexone medication. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the DLA Troop Support Medical facility in Conshohocken, Pennsylvania by December 6, 2023. No set-aside designation was applied to this award issued against an indefinite delivery contract held by Amerisourcebergen with DLA for...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,370.20 firm fixed-price delivery order is for the supply of 60-count Naltrexone 50 mg tablets. The contract has an ultimate completion date of September 11, 2024 and is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to supply 90 tablets of 50mg naltrexone for $1,218.11. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 6, 2023. No set-aside designation was applied to this order, which will deliver pharmaceutical products in support of DLA's provision of medical supplies...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0U4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work at its Conshohocken location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly supplies pharmaceutical products and medical supplies to support military and veteran healthcare systems through competitively awarded contracts with the DLA. Naltrexone, an opioid antagonist medication, represents part of the company's extensive portfolio of generic and brand-name pharmaceuticals delivered to federal customers. The short completion timeline from award to delivery reflects the urgent nature of this pharmaceutical supply requirement for Defense Health Agency and other government healthcare systems served through the DLA's Pharmaceutical Prime Vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 7/30/25 |